Loading clinical trials...
Loading clinical trials...
Exploring the Feasibility of Cerebrospinal Fluid (CSF) Liquid Biopsy in Patients With Metastatic Solid Tumours and Leptomeningeal Disease (Cohort A), Parenchymal Brain Metastases (Cohort B), or No Evidence of Central Nervous System (CNS) Metastases (Cohort C): A Pilot Study
Conditions
Interventions
One time CSF and blood sample
Locations
1
Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Start Date
December 12, 2025
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
March 17, 2026
NCT07486713
NCT06927297
NCT07181473
NCT07299747
NCT07128914
NCT07174453
Lead Sponsor
Sunnybrook Health Sciences Centre
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions